SCHEMBL7065660

SCHEMBL7065660

Cc1ccc(S(=O)(=O)ON(N=Cc2ccc(F)c(Br)c2)C(=N)N)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
MAPT P10636 4/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GFER P55789 1/20 0.38
ATM Q13315 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PTGS2 P35354 3/20 0.34
PTGS1 P23219 2/20 0.34
CA12 O43570 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062979 0.92 GFER (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7064635 0.88 GFER (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7062299 0.87 GFER (0.48) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7062964 0.86 GFER (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7065388 0.84 ATM (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7065963 0.82 MAPT (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7065198 0.82 ATM (0.45) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7065652 0.80 ATM (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7065653 0.80 ATM (0.38) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL7065233 0.80 PTGS2 (0.50) ALDH1A1KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP disclosed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO disclosed